Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Fitoterapia

• Publication date

  2015-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.fitote.2015.01.004PMID 25596095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1.

  2014cited by this paper
• Ultra-high-performance liquid chromatography-tandem mass spectrometry for pharmacokinetics of bakuchiol in rats.

  2014cited by this paper
• Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.

  2014cited by this paper
• Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae.

  2014cited by this paper
• A highly selective long-wavelength fluorescent probe for the detection of human carboxylesterase 2 and its biomedical applications.

  2014cited by this paper
• Recent advances in herbal medicines treating Parkinson's disease.

  2013cited by this paper
• Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

  2013cited by this paper
• Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: review.

  2013cited by this paper
• Development of a fully automated on-line solid phase extraction and high-performance liquid chromatography with diode array detection method for the pharmacokinetic evaluation of bavachinin: a study on absolute bioavailability and dose proportionality.

  2012cited by this paper
• Isolation of a new meroterpene and inhibitors of nitric oxide production from Psoralea corylifolia fruits guided by TLC bioautography.

  2012cited by this paper
• Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.

  2012cited by this paper
• Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2

  2011cited by this paper
• Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.

  2011cited by this paper
• Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line.

  2010cited by this paper
• Chemotherapy: the four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity

  2010cited by this paper
• Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor

  2010cited by this paper
• Human carboxylesterases: an update on CES1, CES2 and CES3.

  2009cited by this paper
• Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs

  2008cited by this paper
• Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs).

  2008cited by this paper
• Chemical fingerprint and quantitative analysis of fructus psoraleae by high-performance liquid chromatography.

  2007cited by this paper
• Studies on the chemical constituents of Psoralea corylifolia L.

  2007cited by this paper
• Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity

  2006cited by this paper
• Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1.

  2006cited by this paper
• Structure, function and regulation of carboxylesterases.

  2006cited by this paper
• Human carboxylesterase isozymes: catalytic properties and rational drug design.

  2006cited by this paper
• Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC-MS.

  2005cited by this paper
• Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.

  2004cited by this paper
• Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.

  2004cited by this paper
• Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.

  2003cited by this paper
• Human carboxylesterase 1: from drug metabolism to drug discovery.

  2003cited by this paper
• Lessons learned from the irinotecan metabolic pathway.

  2003cited by this paper
• Antioxidative components of Psoralea corylifolia (Leguminosae)

  2002cited by this paper
• Current progress on esterases: from molecular structure to function.

  2002cited by this paper
• Gonadal toxicity of an ethanol extract of Psoralea corylifolia in a rat 90-day repeated dose study.

  2002cited by this paper
• Active constituents isolated from Psoralea glandulosa L. with antiinflammatory and antipyretic activities.

  2001cited by this paper
• In Vitro Antimicrobial Activities of Bakuchiol against Oral Microorganisms

  2001cited by this paper
• Inhibition of chemical carcinogenesis by Psoralea corylifolia seeds.

  1999cited by this paper
• The mammalian carboxylesterases: from molecules to functions.

  1998cited by this paper
• Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver.

  1997cited by this paper
• [Measurement of MEFV in 66 cases of asthma in the convalescent stage and after treatment with Chinese herbs].

  1989cited by this paper

• Icaritin enhances the antitumor efficacy of irinotecan by dual-targeting carboxylesterase 2 and p53 in vitro and in vivo.

  2026cites this paper
• Optimization of chemical separation method for isolation of Bakuchiol from seeds of Cullen corylifolium (L.) Medik., Fabaceae

  2025cites this paper
• Evaluation of the inhibitory effects of carbamate pesticides on human carboxylesterases.

  2025cites this paper
• A fluorescent probe for detecting carboxylesterase level on investigating Chinese medicine water decoction efficacy.

  2025cites this paper
• Multimodal discovery of bavachinin A: A natural FLT3 agonist for treating thrombocytopenia.

  2025cites this paper
• Advances on resources, biosynthesis pathway, bioavailability, bioactivity, and application of corylifolinin

  2024cites this paper
• Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro.

  2024cites this paper
• Pharmacokinetics of herb-drug interactions: Experimental models in Nigeria

  2024cites this paper
• Integrated analysis of metabolomic and gut microbiota reveals idiosyncratic drug-induced liver injury resulting from the combined administration of bavachin and icariside II

  2024cites this paper
• Pyrazolone compounds could inhibit CES1 and ameliorates fat accumulation during adipocyte differentiation.

  2024cites this paper
• Kuwanon C inhibits proliferation and induction of apoptosis via the intrinsic pathway in MDA-MB231 and T47D breast cancer cells.

  2024cites this paper
• Therapeutic and Health Promoting Potential of Bakuchiol from Psoralea corylifolia: A Comprehensive Review.

  2023cites this paper
• The cancer preventive activity and mechanisms of prenylated resveratrol and derivatives

  2023cites this paper
• Bakuchiol: A Potential Anticancer Compound from Psoralea corylifolia Linn.

  2023cites this paper
• Bakuchiol – a natural meroterpenoid: structure, isolation, synthesis and functionalization approaches

  2022cites this paper
• Recent Advances in the Chemistry and Biology of Bakuchiol and its Derivatives: An Updated Review.

  2022cites this paper
• Isobavachalcone: A comprehensive review of its plant sources, pharmacokinetics, toxicity, pharmacological activities and related molecular mechanisms

  2022cites this paper
• Ethnopharmacological, Phytochemistry and Pharmacological Activities of Psoralea Corylifolia: A Review

  2022cites this paper
• Psoralea corylifolia Linn: Panacea to several maladies

  2022cites this paper
• Potential determinants for metabolic fates and inhibitory effects of isobavachalcone involving in human cytochrome P450, UDP-glucuronosyltransferase enzymes, and efflux transporters.

  2021cites this paper
• BĀBCHĪ (PSORALEA CORYLIFOLIA LINN.) UNANI MEDICINAL PLANT-A POSSIBLE THERAPEUTIC CANDIDATE FOR COVID SYNDROME

  2021cites this paper
• Carboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism.

  2021cites this paper
• Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase.

  2021cites this paper
• Screening of hepatotoxic compounds in Psoralea corylifolia L., a traditional Chinese herbal and dietary supplement, using high resolution mass spectrometry and high-content imaging.

  2021cites this paper
• Correlation analysis between extracts and endogenous metabolites to characterise the influence of salt-processing on compatibility mechanism of 'Psoraleae Fructus & Foeniculi Fructus'.

  2021cites this paper
• Discovery of Thai mangrove tetranortriterpenoids as agonists of human pregnane-X-receptor and inhibitors against human carboxylesterase 2.

  2020cites this paper
• Fructus Psoraleae–Induced Severe Liver Injury and Treatment With Two Artificial Liver Support Systems: A Case Series Study

  2020cites this paper
• Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system

  2020cites this paper
• Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells

  2020influential citation
• Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies

  2020cites this paper
• Pancreatic lipase inhibitory constituents from Fructus Psoraleae.

  2020cites this paper
• Effects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases

  2020influential citation
• Establishment of a UPLC-MS/MS Method for Studying the Effect of Salt-Processing on Tissue Distribution of Twelve Major Bioactive Components of Qing'e Pills in Rats

  2020cites this paper
• The role of carboxylesterase enzymes in capecitabine therapy

  2020cites this paper
• Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors.

  2020cites this paper
• Potential metabolism determinants and drug–drug interactions of a natural flavanone bavachinin

  2020cites this paper
• Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy

  2020cites this paper
• Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?

  2019cites this paper
• Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.

  2019cites this paper
• Sensitive determination of psoralen and isopsoralen in Fructus Psoraleae by online solid phase microextraction with a porphyrin-based porous organic polymer modified capillary

  2019cites this paper
• Cell Cycle Arrest in Different Cancer Cell Lines (Liver, Breast, and Colon) Induces Apoptosis under the Influence of the Chemical Content of Aeluropus lagopoides Leaf Extracts

  2019cites this paper
• Biologically active prenylated flavonoids from the genus Sophora and their structure–activity relationship—A review

  2019cites this paper
• Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from Schisandra chinensis

  2019cites this paper
• Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus.

  2019cites this paper
• Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism.

  2019cites this paper
• Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1.

  2018cites this paper
• Herbal Compounds Play a Role in Neuroprotection through the Inhibition of Microglial Activation

  2018cites this paper
• Genus Psoralea: A review of the traditional and modern uses, phytochemistry and pharmacology

  2018cites this paper
• Human carboxylesterases: a comprehensive review

  2018cites this paper
• Synthesis and Evaluation of Bakuchiol Derivatives as Potential Anticancer Agents

  2018cites this paper
• In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP‐glucuronosyltransferase enzymes by ultra high‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry

  2018cites this paper
• Progress in Inhibitors against Bacterial β-Glucuronidase in Gastrointestinal Tract

  2018cites this paper
• Qualitative analysis of Psoraleae Fructus by HPLC-DAD/TOF-MS fingerprint and quantitative analysis of multiple components by single marker.

  2018cites this paper
• Evidence for Shikonin acting as an active inhibitor of human carboxylesterases 2: Implications for herb–drug combination

  2018cites this paper
• Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway

  2017cites this paper
• Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1

  2017cites this paper
• Psoralea corylifolia L: Ethnobotanical, biological, and chemical aspects: A review

  2017cites this paper
• Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase.

  2017cites this paper
• [The inhibition of carboxylesterases by praeruptorin C, D and E].

  2017cites this paper
• Highly regioselective glucosylation of alcoholic hydroxyls of protostane triterpenoids mediated by fungal biotransformation

  2017cites this paper
• Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1

  2017cites this paper
• Recent progress in the discovery of natural inhibitors against human carboxylesterases.

  2017cites this paper
• Comparative metabolism of DDAO benzoate in liver microsomes from various species.

  2017cites this paper
• Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.

  2017cites this paper
• Phenolic glycosides and monoterpenoids from the roots of Euphorbia ebracteolata and their bioactivities.

  2017cites this paper
• Phytoestrogen Bakuchiol Exhibits In Vitro and In Vivo Anti-breast Cancer Effects by Inducing S Phase Arrest and Apoptosis

  2016cites this paper
• Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark.

  2016cites this paper
• The natural anthraquinones from Rheum palmatum induced the metabolic disorder of melatonin by inhibiting human CYP and SULT enzymes.

  2016cites this paper
• Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.

  2016cites this paper
• Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells.

  2016cites this paper
• Inhibition behavior of fructus psoraleae’s ingredients towards human carboxylesterase 1 (hCES1)

  2016cites this paper
• Protostane Triterpenoids from the Rhizome of Alisma orientale Exhibit Inhibitory Effects on Human Carboxylesterase 2.

  2015cites this paper
• Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes.

  2015cites this paper
• Progress on pharmacological activities and hepatotoxicity of bavachinin

  year unknowncites this paper